世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2015年
4期
520-522
,共3页
SAP%肠道黏膜屏障功能%炎性因子%复方丹参注射液
SAP%腸道黏膜屏障功能%炎性因子%複方丹參註射液
SAP%장도점막병장공능%염성인자%복방단삼주사액
SAP%Intestinal mucosal barrier function%Inflammatory factor%Compound salvia miltiorrhiza injection
目的:观察复方丹参注射液辅助治疗重症急性胰腺炎(Severe Acute Pancreatitis,SAP)的临床疗效。方法:将本院收治的50例 SAP 住院患者为研究对象,并根据入院先后顺序随机分为对照组和治疗组,2组患者均接受内科常规治疗,如禁食、胃肠减压、扩容、纠正电解质紊乱、抗感染、抑制胰腺分泌、营养支持等,治疗组在上述常规治疗基础上加用复方丹参注射液20 mL 联合0.9%Nacl 溶液250 mL 静脉滴注,每日1次。2组均以10 d 为1个疗程,1个疗程结束后观察2组患者治疗前后症状、体征以及实验室指标的变化。结果:1)治疗组首次排便的时间、肠鸣音恢复时间、腹部压痛消失时间均短于对照组,且差异有统计学意义(P <0.05);2)2组并发症发生率、外科手术中转率及病死率比较均具统计学意义(P <0.05);3)治疗组治疗组血浆内毒素、血清淀粉酶、白细胞计数恢复正常的时间均短于对照组(P <0.05),经过治疗后治疗组血清肿瘤坏死因子-α(Tumor Necrosis Factor alpha,TNF-α)、白细胞介素-8(Interleukin-8,IL-8)、白细胞介素-6(Interleu-kin-6,IL-6)水平明显低于对照组(P <0.05)。结论:复方丹参注射液辅助治疗 SAP 可促进胃肠功能恢复,降低并发症发生率及病死率,临床可进一步推广。
目的:觀察複方丹參註射液輔助治療重癥急性胰腺炎(Severe Acute Pancreatitis,SAP)的臨床療效。方法:將本院收治的50例 SAP 住院患者為研究對象,併根據入院先後順序隨機分為對照組和治療組,2組患者均接受內科常規治療,如禁食、胃腸減壓、擴容、糾正電解質紊亂、抗感染、抑製胰腺分泌、營養支持等,治療組在上述常規治療基礎上加用複方丹參註射液20 mL 聯閤0.9%Nacl 溶液250 mL 靜脈滴註,每日1次。2組均以10 d 為1箇療程,1箇療程結束後觀察2組患者治療前後癥狀、體徵以及實驗室指標的變化。結果:1)治療組首次排便的時間、腸鳴音恢複時間、腹部壓痛消失時間均短于對照組,且差異有統計學意義(P <0.05);2)2組併髮癥髮生率、外科手術中轉率及病死率比較均具統計學意義(P <0.05);3)治療組治療組血漿內毒素、血清澱粉酶、白細胞計數恢複正常的時間均短于對照組(P <0.05),經過治療後治療組血清腫瘤壞死因子-α(Tumor Necrosis Factor alpha,TNF-α)、白細胞介素-8(Interleukin-8,IL-8)、白細胞介素-6(Interleu-kin-6,IL-6)水平明顯低于對照組(P <0.05)。結論:複方丹參註射液輔助治療 SAP 可促進胃腸功能恢複,降低併髮癥髮生率及病死率,臨床可進一步推廣。
목적:관찰복방단삼주사액보조치료중증급성이선염(Severe Acute Pancreatitis,SAP)적림상료효。방법:장본원수치적50례 SAP 주원환자위연구대상,병근거입원선후순서수궤분위대조조화치료조,2조환자균접수내과상규치료,여금식、위장감압、확용、규정전해질문란、항감염、억제이선분비、영양지지등,치료조재상술상규치료기출상가용복방단삼주사액20 mL 연합0.9%Nacl 용액250 mL 정맥적주,매일1차。2조균이10 d 위1개료정,1개료정결속후관찰2조환자치료전후증상、체정이급실험실지표적변화。결과:1)치료조수차배편적시간、장명음회복시간、복부압통소실시간균단우대조조,차차이유통계학의의(P <0.05);2)2조병발증발생솔、외과수술중전솔급병사솔비교균구통계학의의(P <0.05);3)치료조치료조혈장내독소、혈청정분매、백세포계수회복정상적시간균단우대조조(P <0.05),경과치료후치료조혈청종류배사인자-α(Tumor Necrosis Factor alpha,TNF-α)、백세포개소-8(Interleukin-8,IL-8)、백세포개소-6(Interleu-kin-6,IL-6)수평명현저우대조조(P <0.05)。결론:복방단삼주사액보조치료 SAP 가촉진위장공능회복,강저병발증발생솔급병사솔,림상가진일보추엄。
Objective:To observe the clinical curative effect of the compound salvia miltiorrhiza injection in adjuvant therapy of severe acute pancreatitis (SAP).Methods:Fifty patients with SAP were received and treated in our hospital.They were randomly divided into the control group and the treatment group.Both groups received conventional treatment,i.e.fasting,gastrointestinal de-compression,expansion of blood volume,correction of electrolyte disturbances,anti-infection therapy,inhibition of pancreatic secre-tion,nutritional support,etc.On top of conventional treatment,the treatment group received intravenous drip of 20 ml compound sal-via miltiorrhiza injection combined with 250ml 0.9% NaCl solution,once per day.Both groups received 10 days of treatment,and were observed of the changes in symptoms,signs and laboratory indexes before and after treatment.Results:1 )First defecation time,bowel sound recovery time,and abdominal tenderness disappear time of the treatment group were shorter than that of the con-trol group,and the differences were statistically significant (P <0.05);2)Complications rate,surgical operation rate and case fa-tality rate of the two groups were with statistical differences (P <0.05);3)In the treatment group,the time of plasma endotoxin, serum amylase,the leukocyte count all returned to normal,which were better than that of the control group (P <0.05).After treat-ment,serum Tumor Necrosis Factor alpha (TNF alpha),interleukin-8 (IL-8)and interleukin-6 (IL-6)level of the treatment group were significantly lower than that of the control group (P <0.05).Conclusion:The application of compound salvia miltiorrhiza in-jection in the adjuvant therapy of SAP can promote the recovery of gastrointestinal function and reduce the incidence of complica-tions and case fatality,thus is suggested to be further promoted in clinical practice.